United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing

By Reuters News

- United Therapeutics Corporation UTHR.O:

  • UNITED THERAPEUTICS CORP - ENTERS SETTLEMENT AGREEMENT WITH LIQUIDIA TO RESOLVE LITIGATION - SEC FILING

  • UNITED THERAPEUTICS CORP - LIQUIDIA TO PAY UNITED THERAPEUTICS $330.40 MILLION UNDER SETTLEMENT AGREEMENT - SEC FILING

  • UNITED THERAPEUTICS CORP - PARTIES TO SEEK DISMISSAL OF LITIGATION WITHIN TEN DAYS AFTER $185 MILLION PAYMENT - SEC FILING

  • UNITED THERAPEUTICS CORP - LIQUIDIA TO CEASE SALES OF YUTREPIA WITH PH-ILD INDICATION UPON FDA APPROVAL - SEC FILING

  • UNITED THERAPEUTICS CORP - LIQUIDIA TO MARKET YUTREPIA ONLY TO PRACTITIONERS TREATING PAH - SEC FILING

  • UNITED THERAPEUTICS CORP - LIQUIDIA TO TERMINATE ASCENT TRIAL COHORTS STUDYING PH-ILD AND CEASE DATA PUBLICATION - SEC FILING

Source text: [ID:n0001104659-26-115723]

Further company coverage: UTHR.O

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk